A bispecific antibody recognizing influenza A virus M2 protein redirects effector cells to inhibit virus replication in vitro

Journal of Virology

Volumn 70, Issue 7, 1996, Pages 4800-4804

  Fernandez Sesma, Ana ^a   Schulman, Jerome L ^a   Moran, Thomas M ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BISPECIFIC ANTIBODY; T LYMPHOCYTE RECEPTOR;

ANTIGEN RECOGNITION; ARTICLE; CYTOTOXIC T LYMPHOCYTE; IMMUNOTHERAPY; MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION; PRIORITY JOURNAL; VIRUS INHIBITION; VIRUS REPLICATION;

EID: 0030014169     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.70.7.4800-4804.1996     Document Type: Article

References (29)

1. Berg, J., E. Lotscher, K. S. Steimer, D. J. Capon, J. Baenziger, H.-M. Jack, and M. Wabl. 1991. Bispecific antibodies that mediate killing of cells infected with human immunodeficiency virus of any strain. Proc. Natl. Acad. Sci. USA 88:4723-4727.
2. Chisari, F. V., and C. Ferrari. 1995. Hepatitis B virus immunopathogenesis. Annu. Rev. Immunol. 13:29-60.
3. De Lau, W. B., K. Heije, J. J. Neefjes, M. Oosterwegel, E. Rozemuller, and B. J. Bast. 1991. Absence of preferential homologous H/L chain association in hybrid hybridomas. J. Immunol. 146:906-914.
4. Doherty, P. C., W. Allan, and M. Eichelberger. 1992. Roles of αβ and γδ T cell subsets in viral immunity. Annu. Rev. Immunol. 10:123-151.
5. Fanger, M. W., P. M. Morganelli, and P. M. Guyre. 1992. Bispecific antibodies. Crit. Rev. Immunol. 12(3-4):101-124.
6. Fanger, M. W., D. M. Segal, and J. L. Romet-Lemonne. 1991. Bispecific antibodies and targeted cellular cytotoxicity. Immunol. Today 12(2):51-54.
7. Fleischer, B., and H. Schrezenmeier. 1988. T cell Stimulation by staphylococcal enterotoxins. Clonally variable response and requirement for major histocompatibility complex class II molecules on accessory or target cells. J. Exp. Med. 167:1697-1707.
8. Gruber, M., B. A. Schodin, E. R. Wilson, and D. M. Kranz. 1994. Efficient tumor cell lysis mediated by a bispecific single-chain antibody expressed in Escherichia coli. J. Immunol. 152:5368-5374.
9. Herman, A., J. W. Kappler, P. Marrack, and A. M. Pullen. 1991. Superantigens: mechanism of T cell stimulation and role in immune responses. Annu. Rev. Immunol. 9:745-772.
10. Howell, A. L., P. M. Guyre, K.-S. You, and M. W. Fanger. Targeting HIV-1 to FcγR on human phagocytes via bispecific antibodies reduces infectivity of HIV-1 to T cells. J. Leukocyte Biol. 55:385-391.
11. Kohler, G., and C. Milstein. 1975. Continuous cultures of fused cells secreting antibody of predefined specificity. Nature (London) 256:495-497.
12. Kurucz, I., J. A. Titus, C. R. Jost, C. M. Jacobus, and D. M. Segal. 1995. Retargeting of CTL by an efficiently refolded bispecific single-chain Fv dimer produced in bacteria. J. Immunol. 154:4576-4582.
13. Lamb, R. A., S. L. Zebedee, and C. D. Richardson. 1985. Influenza virus M2 protein is an integral membrane protein expressed on the infected cell surface. Cell 40:627-633.
14. Milstein, C., and A. C. Cuello. 1983. Hybrid hybridomas and their use in immunochemistry. Nature (London) 305:537-541.
15. Milstein, C., and A. C. Cuello. 1984. Hybrid hybridomas and the production of bi-specific monoclonal antibodies. Immunol. Today 5(10):299-304.
16. Moran, T. M., E. Toy, Y. Kuzu, H. Kuzu, H. Isobe, and J. L. Schulman. 1995. Staphylococcal enterotoxin B-activated T cells can be redirected to inhibit multicycle virus replication. J. Immunol. 155:759-765.
17. Moran, T. M., O. Usuba, H. Kuzu, Y. Kuzu, J. Schulman, and C. A. Bona. 1991. Inhibition of multicycle influenza virus replication by hybrid antibody-directed cytotoxic T lymphocyte lysis. J. Immunol. 146:321-326.
18. Paya, C., D. J. McKean, D. M. Segal, R. A. Schoon, S. D. Showalter, and P. J. Leibson. 1989. Heteroconjugate antibodies enhance cell mediated anti-herpes simplex virus immunity. J. Immunol. 142:666-671.
19. Penna, C., P. A. Dean, and H. Nelson. 1994. Antitumor × anti-CD3 bifunctional antibodies redirect T cells activated in vivo with staphylococcal enterotoxin B to neutralize pulmonary metastases. Cancer Res. 54:2738-2743.
20. Perez, P., R. W. Hoffman, S. Shaw, J. A. Bluestone, and D. M. Segal. 1985. Specific targeting of cytotoxic T cells by anti-T3 linked to anti-target cell antibody. Nature (London) 316:354-356.
21. Pinto, L. H., L. J. Holsinger, and R. A. Lamb. 1992. Influenza virus M2 protein has ion channel activity. Cell 69:517-528.
22. 21a.Rao, H. G. V., and T. M. Moran. Unpublished results.
23. Reed, L. J., and H. Muench. 1938. A simple method of estimating fifty percent end points. Am. J. Hyg. 27:493-497.
24. Ridell, S. R., and P. D. Greenberg. 1995. Principles for adoptive T cell therapy of human viral diseases. Annu. Rev. Immunol. 13:545-586.
25. Staerz, U. D., and M. J. Bevan. 1986. Hybrid hybridoma producing a bispecific monoclonal antibody that can focus effector T cell activity. Proc. Natl. Acad. Sci. USA 83:1453-1457.
26. Titus, J. A., M. A. Garrido, T. T. Hecht, D. F. Winker, J. R. Wunderlich, and D. M. Segal. 1987. Human T cells targeted with anti-T3 cross-linked to antitumor antibody prevent tumor growth in nude mice. J. Immunol. 138: 4018-4022.
27. Weiner, G. J., and J. R. Hillstrom. 1991. Bispecific anti-idiotype/anti-CD3 antibody therapy of murine B cell lymphoma. J. Immunol. 147:4035-4044.
28. White, J., A. Herman, A. M. Pullen, R. Kubo, J. W. Kappler, and P. Marrack. 1989. The Vβ-specific superantigen staphylococcal enterotoxin B: stimulation of mature T cells and clonal deletion in neonatal mice. Cell 56:27-35.
29. Winter, G., and C. Milstein. 1991. Man-made antibodies. Nature (London) 349:293-299.